Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome.

导出 LinkOut

翻译打印收藏纠错

第一作者： Robin,Reschke

第一单位： Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases, Heidelberg University, Heidelberg, Germany.;German Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany.;German Cancer Research Center, Heidelberg, Germany.

作者： Robin,Reschke ^[1] ; Jasmin,Richter ^[2] ; Alexander H,Enk ^[2] ; Jessica C,Hassel ^[1]

作者单位： Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases, Heidelberg University, Heidelberg, Germany.;German Cancer Consortium, Core Center Heidelberg, Heidelberg, Germany.;German Cancer Research Center, Heidelberg, Germany. ^[1] Medical Faculty Heidelberg, Department of Dermatology and National Center for Tumor Diseases, Heidelberg University, Heidelberg, Germany. ^[2]

DOI 10.1001/jamadermatol.2024.4445

PMID 39504038

发布时间 2025-01-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA dermatology

2025年161卷1期

104-105页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome.

JAMA dermatology

相似文献

JAMA dermatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome.

JAMA dermatology

相似文献

JAMA dermatology

相关期刊

检索历史清除